FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Genzyme Funding Knee Osteoarthritis Education

[ Price : $8.95]

Genzyme funds an educational program to urge those with osteoarthritis of the knee to discuss treatment options with their doctor.

FDA Warns of Possible Tamiflu Dosing Errors

[ Price : $8.95]

FDAs MedWatch programs calls on doctors and pharmacists to be sure prescription instructions for Tamiflu match the dosing device i...

NicOx NDA Submitted for Arthritis Drug

[ Price : $8.95]

NicOx submits an NDA for naproxcinod, indicated for relieving the signs and symptoms of osteoarthritis.

Quintiles and Allergan to Co-promote Santura XR

[ Price : $8.95]

Quintiles Transnational and Allergan reach an agreement where Quintiles will co-promote Allergan's Sanctura XR for treating overac...

FDA Tobacco Act Deems Flavored Cigarettes Adulterated

[ Price : $8.95]

Federal Register Notice: FDA reminds interested parties that in accordance with the Family Smoking Prevention and Tobacco Control ...

Panel to Discuss BLA for Anthrax

[ Price : $8.95]

Federal Register Notice: FDAs Anti-Infective Drugs Advisory Committee will meet 10/27 to discuss a Human Genome Sciences BLA for r...

FDA Corrects ANDA Withdrawal Notice

[ Price : $8.95]

Federal Register Notice: FDA corrects the ANDA identification number for one ANDA in a 2/11 Federal Register notice announcing the...

FDA Wants Januvia Labeling Changes to Reflect Pancreatitis Cases

[ Price : $8.95]

FDA says it wants labeling for Mercks Januvia and Janumet changed to call attention to reports of acute pancreatitis in patients t...

FDA Unique Device Identification Code Awaits Foreign Input

[ Price : $8.95]

FDA says its proposed rule on a unique device identification code for medical devices will be globally based and laid out in a pro...

FDA Clears Cepheid Test for Thrombophilia

[ Price : $8.95]

FDA clears Cepheids Xpert HemosIL FII and FV test to detect Factor II and Factor V Leiden generic variations associated with throm...